| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.02▲ | 4.97▲ | 4.97▲ | 5.06▼ | 4.56▲ |
| MA10 | 4.99▲ | 4.95▲ | 4.97▲ | 5.10▼ | 3.98▲ |
| MA20 | 4.97▲ | 4.99▲ | 5.02▲ | 4.68▲ | 3.60▲ |
| MA50 | 4.95▲ | 5.04▲ | 5.09▼ | 3.91▲ | 3.23▲ |
| MA100 | 5.00▲ | 5.10▼ | 5.15▼ | 3.55▲ | 3.65▲ |
| MA200 | 5.04▼ | 5.07▼ | 4.24▲ | 3.31▲ | 3.39▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.007▲ | 0.000▼ | -0.030▼ | 0.216▲ |
| RSI | 72.094▲ | 56.548▲ | 51.204▲ | 61.664▲ | 64.662▲ |
| STOCH | 94.286▲ | 56.642 | 22.388 | 26.249 | 57.385 |
| WILL %R | 0.000▲ | 0.000▲ | -40.909 | -73.050 | -33.882 |
| CCI | 135.758▲ | 286.022▲ | 13.163 | -75.987 | 145.050▲ |
| CDL | $PBYI Doji Candlestick Pattern Detected | Set Alert |
|
Thursday, August 07, 2025 09:51 PM
Puma Biotechnology (NASDAQ:PBYI) develops and commercializes treatments for cancer, with a particular focus on breast cancer. Its core medicine is NERLYNX, an oral drug for HER2-positive breast ...
|
|
Friday, June 27, 2025 08:02 AM
One stock to keep an eye on is Puma Biotechnology (PBYI). PBYI is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. Investors should also note that PBYI holds a PEG ratio of ...
|
|
Friday, May 09, 2025 02:39 AM
PBYI's PEG compares to its industry's average PEG of 2.45. Over the past 52 weeks, PBYI's PEG has been as high as 1.79 and as low as 1.38, with a median of 1.51.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/08/25 | 5.03 | 5.04 | 4.91 | 5.04 | 378,843 |
| 28/08/25 | 5.10 | 5.13 | 4.93 | 4.97 | 416,132 |
| 27/08/25 | 5.14 | 5.148 | 4.9568 | 5.10 | 568,648 |
| 26/08/25 | 5.01 | 5.22 | 4.90 | 5.18 | 639,543 |
| 25/08/25 | 5.30 | 5.325 | 4.90 | 4.99 | 525,846 |
| 22/08/25 | 5.23 | 5.37 | 5.04 | 5.25 | 671,890 |
| 21/08/25 | 5.09 | 5.40 | 5.075 | 5.22 | 820,742 |
| 20/08/25 | 5.078 | 5.215 | 4.96 | 5.11 | 687,541 |
| 19/08/25 | 5.00 | 5.315 | 4.835 | 5.09 | 1,258,310 |
| 18/08/25 | 5.81 | 6.07 | 4.81 | 5.005 | 1,706,492 |
|
|
||||
|
|
||||
|
|